Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 3.48M | 4.69M | 5.94M | 6.24M | 6.53M |
| Total Revenue | 3.48M | 4.69M | 5.94M | 6.24M | 6.53M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.48M | 4.69M | 5.94M | 6.24M | 6.53M |
| SG&A Expenses | 5.25M | 5.05M | 4.89M | 4.83M | 4.75M |
| Depreciation & Amortization | 273.20K | 270.30K | 268.80K | 271.90K | 273.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.44M | 12.94M | 12.52M | 13.89M | 15.20M |
| Operating Income | -9.96M | -8.25M | -6.58M | -7.65M | -8.67M |
| Income Before Tax | -9.56M | -7.95M | -6.38M | -7.48M | -8.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.56 | -7.95 | -6.38 | -7.48 | -8.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.56M | -7.95M | -6.38M | -7.48M | -8.53M |
| EBIT | -9.96M | -8.25M | -6.58M | -7.65M | -8.67M |
| EBITDA | -9.74M | -8.03M | -6.37M | -7.44M | -8.45M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 11.92B | 11.16B | 10.40B | 9.55B | 8.70B |
| Average Diluted Shares Outstanding | 11.92B | 11.16B | 10.40B | 9.55B | 8.70B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |